These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 15817396)

  • 1. Signalling by PI3K isoforms: insights from gene-targeted mice.
    Vanhaesebroeck B; Ali K; Bilancio A; Geering B; Foukas LC
    Trends Biochem Sci; 2005 Apr; 30(4):194-204. PubMed ID: 15817396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles for isoforms of the catalytic subunit of class-IA PI3K in the regulation of behaviour of murine embryonic stem cells.
    Kingham E; Welham M
    J Cell Sci; 2009 Jul; 122(Pt 13):2311-21. PubMed ID: 19509054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging mechanisms of isoform-specific PI3K signalling.
    Vanhaesebroeck B; Guillermet-Guibert J; Graupera M; Bilanges B
    Nat Rev Mol Cell Biol; 2010 May; 11(5):329-41. PubMed ID: 20379207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K signalling in inflammation.
    Hawkins PT; Stephens LR
    Biochim Biophys Acta; 2015 Jun; 1851(6):882-97. PubMed ID: 25514767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling.
    Chaussade C; Rewcastle GW; Kendall JD; Denny WA; Cho K; Grønning LM; Chong ML; Anagnostou SH; Jackson SP; Daniele N; Shepherd PR
    Biochem J; 2007 Jun; 404(3):449-58. PubMed ID: 17362206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K isoforms in cell signalling and vesicle trafficking.
    Bilanges B; Posor Y; Vanhaesebroeck B
    Nat Rev Mol Cell Biol; 2019 Sep; 20(9):515-534. PubMed ID: 31110302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.
    Mouta-Bellum C; Kirov A; Miceli-Libby L; Mancini ML; Petrova TV; Liaw L; Prudovsky I; Thorpe PE; Miura N; Cantley LC; Alitalo K; Fruman DA; Vary CP
    Dev Dyn; 2009 Oct; 238(10):2670-9. PubMed ID: 19705443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-targeting reveals physiological roles and complex regulation of the phosphoinositide 3-kinases.
    Foukas LC; Okkenhaug K
    Arch Biochem Biophys; 2003 Jun; 414(1):13-8. PubMed ID: 12745249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
    Gross C; Nakamoto M; Yao X; Chan CB; Yim SY; Ye K; Warren ST; Bassell GJ
    J Neurosci; 2010 Aug; 30(32):10624-38. PubMed ID: 20702695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of class I, II and III PI 3-kinases in platelet production and activation and their implication in thrombosis.
    Valet C; Severin S; Chicanne G; Laurent PA; Gaits-Iacovoni F; Gratacap MP; Payrastre B
    Adv Biol Regul; 2016 May; 61():33-41. PubMed ID: 26714793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.
    Alliouachene S; Bilanges B; Chaussade C; Pearce W; Foukas LC; Scudamore CL; Moniz LS; Vanhaesebroeck B
    Diabetologia; 2016 Jul; 59(7):1503-1512. PubMed ID: 27138914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K in lymphocyte development, differentiation and activation.
    Okkenhaug K; Vanhaesebroeck B
    Nat Rev Immunol; 2003 Apr; 3(4):317-30. PubMed ID: 12669022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterisation of tetracycline-regulated phosphoinositide 3-kinase mutants: assessing the role of multiple phosphoinositide 3-kinases in chemokine signaling.
    Curnock AP; Ward SG
    J Immunol Methods; 2003 Feb; 273(1-2):29-41. PubMed ID: 12535795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent patents of gene sequences relative to the phosphatidylinositol 3-kinase/Akt pathway and their relevance to drug discovery.
    Doepfner KT; Boller D; De Laurentiis A; Guerreiro AS; Marinov M; Arcaro A
    Recent Pat DNA Gene Seq; 2007; 1(1):9-23. PubMed ID: 19075915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twice upon a time: PI3K's secret double life exposed.
    Hirsch E; Braccini L; Ciraolo E; Morello F; Perino A
    Trends Biochem Sci; 2009 May; 34(5):244-8. PubMed ID: 19376709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoinositide 3-kinase as a therapeutic target in angiogenic disease.
    Wu W; Xia X; Tang L; Luo J; Xiong S; Ma G; Lei H
    Exp Eye Res; 2023 Nov; 236():109646. PubMed ID: 37716399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K-signalling in B- and T-cells: insights from gene-targeted mice.
    Okkenhaug K; Vanhaesebroeck B
    Biochem Soc Trans; 2003 Feb; 31(Pt 1):270-4. PubMed ID: 12546700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
    Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of phosphoinositide 3-kinase expression in health and disease.
    Kok K; Geering B; Vanhaesebroeck B
    Trends Biochem Sci; 2009 Mar; 34(3):115-27. PubMed ID: 19299143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis.
    Bone HK; Welham MJ
    J Cell Sci; 2007 May; 120(Pt 10):1752-62. PubMed ID: 17456549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.